TPM1 and cancer: It was also reported that Tropomyosin-1, a widely expressed actin-binding protein, could promote cancer cell apoptosis via the p53-mediated mitochondrial pathway in ccRCC [24], and the MDM2 inhibitor MI-319 could induce RCC cell apoptosis mainly dependent on p53 overexpression [25].